428
Views
25
CrossRef citations to date
0
Altmetric
Review

A comprehensive patents review on cannabinoid 1 receptor antagonists as antiobesity agents

, , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

George Amato, Nayaab S Khan & Rangan Maitra. (2019) A patent update on cannabinoid receptor 1 antagonists (2015-2018). Expert Opinion on Therapeutic Patents 29:4, pages 261-269.
Read now

Articles from other publishers (24)

Thomas Högberg, Jean-Marie Receveur, Anthony Murray, Jean-Michel Linget, Pia K. Nørregaard, Paul B. Little & Martin Cooper. (2024) Optimizing and characterizing 4-methyl substituted pyrazol-3-carboxamides leading to the peripheral cannabinoid 1 receptor inverse agonist TM38837. Bioorganic & Medicinal Chemistry Letters 98, pages 129572.
Crossref
Raj Kamal Srivastava, Inigo Ruiz de Azua, Andrea Conrad, Martin Purrio & Beat Lutz. (2022) Cannabinoid CB1 Receptor Deletion from Catecholaminergic Neurons Protects from Diet-Induced Obesity. International Journal of Molecular Sciences 23:20, pages 12635.
Crossref
Thuy Nguyen, Thomas F. Gamage, David B. Finlay, Ann M. Decker, Tiffany L. Langston, Daniel Barrus, Michelle Glass, Jun-Xu Li, Terry P. Kenakin & Yanan Zhang. (2021) Development of 3-(4-Chlorophenyl)-1-(phenethyl)urea Analogues as Allosteric Modulators of the Cannabinoid Type-1 Receptor: RTICBM-189 is Brain Penetrant and Attenuates Reinstatement of Cocaine-Seeking Behavior. Journal of Medicinal Chemistry 65:1, pages 257-270.
Crossref
Iona J. MacDonald & Yi-Hung Chen. (2021) The Endocannabinoid System Contributes to Electroacupuncture Analgesia. Frontiers in Neuroscience 14.
Crossref
Paula Morales & Patricia H. Reggio. 2021. Cannabinoids and Neuropsychiatric Disorders. Cannabinoids and Neuropsychiatric Disorders 47 65 .
Robert Ettaro, Lucas Laudermilk, Stewart D. Clark & Rangan Maitra. (2020) Behavioral assessment of rimonabant under acute and chronic conditions. Behavioural Brain Research 390, pages 112697.
Crossref
Juan A. Páez & Nuria E. Campillo. (2019) Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer’s Disease and Less Well-Known Diseases. Current Medicinal Chemistry 26:18, pages 3300-3340.
Crossref
George Amato, Robert Wiethe, Amruta Manke, Vineetha Vasukuttan, Rodney Snyder, Scott Runyon & Rangan Maitra. (2019) Functionalized 6-(piperidin-1-yl)-8,9-diphenyl purines as inverse agonists of the CB1 receptor – SAR efforts towards selectivity and peripheralization. Bioorganic & Medicinal Chemistry 27:16, pages 3632-3649.
Crossref
George Amato, Amruta Manke, Robert Wiethe, Vineetha Vasukuttan, Rodney Snyder, Yun Lan Yueh, Ann Decker, Scott Runyon & Rangan Maitra. (2019) Functionalized 6-(Piperidin-1-yl)-8,9-Diphenyl Purines as Peripherally Restricted Inverse Agonists of the CB1 Receptor. Journal of Medicinal Chemistry 62:13, pages 6330-6345.
Crossref
Mesfin YimamPing JiaoMei HongLidia BrownellYoung-Chul LeeHyun-Jin KimJeong-Bum NamMi-Ran KimQi Jia. (2019) Morus alba , a Medicinal Plant for Appetite Suppression and Weight Loss . Journal of Medicinal Food 22:7, pages 741-751.
Crossref
David R. Janero, V. Kiran Vemuri & Alexandros Makriyannis. 2019. Cannabis Use Disorders. Cannabis Use Disorders 43 54 .
Thomas Rossolini, Jamie A. Leitch, Rachel Grainger & Darren J. Dixon. (2018) Photocatalytic Three-Component Umpolung Synthesis of 1,3-Diamines. Organic Letters 20:21, pages 6794-6798.
Crossref
Jorge Manzanares, David Cabañero, Nagore Puente, María S. García-Gutiérrez, Pedro Grandes & Rafael Maldonado. (2018) Role of the endocannabinoid system in drug addiction. Biochemical Pharmacology 157, pages 108-121.
Crossref
Mange Ram Yadav & Prashant R Murumkar. (2018) Advances in patented CB1 receptor antagonists for obesity. Pharmaceutical Patent Analyst 7:5, pages 169-173.
Crossref
George S. Amato, Amruta Manke, Vineetha Vasukuttan, Robert W. Wiethe, Rodney W. Snyder, Scott P. Runyon & Rangan Maitra. (2018) Synthesis and pharmacological characterization of functionalized 6-piperazin-1-yl-purines as cannabinoid receptor 1 (CB1) inverse agonists. Bioorganic & Medicinal Chemistry 26:15, pages 4518-4531.
Crossref
Mayank Kumar Sharma, Jatin Machhi, Prashant Murumkar & Mange Ram Yadav. (2018) New role of phenothiazine derivatives as peripherally acting CB1 receptor antagonizing anti-obesity agents. Scientific Reports 8:1.
Crossref
Mahesh A. Barmade,Mayank K. Sharma. 2018. Vicinal Diaryl Substituted Heterocycles. Vicinal Diaryl Substituted Heterocycles 363 399 .
Atul N. Khadse & Mahesh A. Barmade. 2018. Vicinal Diaryl Substituted Heterocycles. Vicinal Diaryl Substituted Heterocycles 327 362 .
Prashant R. Murumkar & Rupesh V. Chikhale. 2018. Vicinal Diaryl Substituted Heterocycles. Vicinal Diaryl Substituted Heterocycles 191 219 .
Lizi Xia, Henk de Vries, Eelke B. Lenselink, Julien Louvel, Michael J. Waring, Leifeng Cheng, Sara Pahlén, Maria J. Petersson, Peter Schell, Roine I. Olsson, Laura H. Heitman, Robert J. Sheppard & Adriaan P. IJzerman. (2017) Structure–Affinity Relationships and Structure–Kinetic Relationships of 1,2-Diarylimidazol-4-carboxamide Derivatives as Human Cannabinoid 1 Receptor Antagonists. Journal of Medicinal Chemistry 60:23, pages 9545-9564.
Crossref
Isvett Josefina Flores-Sanchez & Ana Carmela Ramos-Valdivia. (2016) A review from patents inspired by the genus Cannabis. Phytochemistry Reviews 16:4, pages 639-675.
Crossref
Emily E Thompson, Julia E Jagielo-Miller, V Kiran Vemuri, Alexandros Makriyannis & Peter J McLaughlin. (2016) CB1 antagonism produces behaviors more consistent with satiety than reduced reward value in food-maintained responding in rats. Journal of Psychopharmacology 30:5, pages 482-491.
Crossref
Patrice D. Cani, Hubert Plovier, Matthias Van Hul, Lucie Geurts, Nathalie M. Delzenne, Céline Druart & Amandine Everard. (2015) Endocannabinoids — at the crossroads between the gut microbiota and host metabolism. Nature Reviews Endocrinology 12:3, pages 133-143.
Crossref
Mayank Kumar Sharma, Prashant R. Murumkar, Guanglin Kuang, Yun Tang & Mange Ram Yadav. (2016) Identifying the structural features and diversifying the chemical domain of peripherally acting CB1 receptor antagonists using molecular modeling techniques. RSC Advances 6:2, pages 1466-1483.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.